308 related articles for article (PubMed ID: 34182017)
1. High-throughput proteomics and AI for cancer biomarker discovery.
Xiao Q; Zhang F; Xu L; Yue L; Kon OL; Zhu Y; Guo T
Adv Drug Deliv Rev; 2021 Sep; 176():113844. PubMed ID: 34182017
[TBL] [Abstract][Full Text] [Related]
2. [Advances in high-throughput proteomic analysis].
Wu Q; Sui X; Tian R
Se Pu; 2021 Feb; 39(2):112-117. PubMed ID: 34227342
[TBL] [Abstract][Full Text] [Related]
3. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.
Qian WJ; Jacobs JM; Liu T; Camp DG; Smith RD
Mol Cell Proteomics; 2006 Oct; 5(10):1727-44. PubMed ID: 16887931
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
Jimenez CR; Verheul HM
Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
[TBL] [Abstract][Full Text] [Related]
5. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
6. Use of monolithic supports for high-throughput protein and peptide separation in proteomics.
Andjelković U; Tufegdžić S; Popović M
Electrophoresis; 2017 Nov; 38(22-23):2851-2869. PubMed ID: 28906564
[TBL] [Abstract][Full Text] [Related]
7. Early Cancer Biomarker Discovery Using DIA-MS Proteomic Analysis of EVs from Peripheral Blood.
Espejo C; Lyons B; Woods GM; Wilson R
Methods Mol Biol; 2023; 2628():127-152. PubMed ID: 36781783
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.
Huang R; Chen Z; He L; He N; Xi Z; Li Z; Deng Y; Zeng X
Theranostics; 2017; 7(14):3559-3572. PubMed ID: 28912895
[TBL] [Abstract][Full Text] [Related]
9. Why have so few proteomic biomarkers "survived" validation? (Sample size and independent validation considerations).
Hernández B; Parnell A; Pennington SR
Proteomics; 2014 Jul; 14(13-14):1587-92. PubMed ID: 24737731
[TBL] [Abstract][Full Text] [Related]
10. Corra: Computational framework and tools for LC-MS discovery and targeted mass spectrometry-based proteomics.
Brusniak MY; Bodenmiller B; Campbell D; Cooke K; Eddes J; Garbutt A; Lau H; Letarte S; Mueller LN; Sharma V; Vitek O; Zhang N; Aebersold R; Watts JD
BMC Bioinformatics; 2008 Dec; 9():542. PubMed ID: 19087345
[TBL] [Abstract][Full Text] [Related]
11. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
[TBL] [Abstract][Full Text] [Related]
12. Clinical proteomics: liquid chromatography-mass spectrometry purification systems.
Henry M; Meleady P
Methods Mol Biol; 2011; 681():473-83. PubMed ID: 20978984
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
[TBL] [Abstract][Full Text] [Related]
14. Development of a Multiplexed Liquid Chromatography Multiple-Reaction-Monitoring Mass Spectrometry (LC-MRM/MS) Method for Evaluation of Salivary Proteins as Oral Cancer Biomarkers.
Chen YT; Chen HW; Wu CF; Chu LJ; Chiang WF; Wu CC; Yu JS; Tsai CH; Liang KH; Chang YS; Wu M; Ou Yang WT
Mol Cell Proteomics; 2017 May; 16(5):799-811. PubMed ID: 28235782
[TBL] [Abstract][Full Text] [Related]
15. Approaches for targeted proteomics and its potential applications in neuroscience.
Sethi S; Chourasia D; Parhar IS
J Biosci; 2015 Sep; 40(3):607-27. PubMed ID: 26333406
[TBL] [Abstract][Full Text] [Related]
16. Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies.
Wang M; Tsai TH; Di Poto C; Ferrarini A; Yu G; Ressom HW
BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):545. PubMed ID: 27535232
[TBL] [Abstract][Full Text] [Related]
17. Review of Liquid Chromatography-Mass Spectrometry-Based Proteomic Analyses of Body Fluids to Diagnose Infectious Diseases.
Lee H; Kim SI
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216306
[TBL] [Abstract][Full Text] [Related]
18. Clinical proteomics in cancer: Where we are.
Panis C; Pizzatti L; Souza GF; Abdelhay E
Cancer Lett; 2016 Nov; 382(2):231-239. PubMed ID: 27561426
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of mass spectrometry-based proteomics in cancer: Where are we?
Boys EL; Liu J; Robinson PJ; Reddel RR
Proteomics; 2023 Apr; 23(7-8):e2200238. PubMed ID: 35968695
[TBL] [Abstract][Full Text] [Related]
20. The Future of Proteomics is Up in the Air: Can Ion Mobility Replace Liquid Chromatography for High Throughput Proteomics?
Jiang Y; DeBord D; Vitrac H; Stewart J; Haghani A; Van Eyk JE; Fert-Bober J; Meyer JG
J Proteome Res; 2024 Jun; 23(6):1871-1882. PubMed ID: 38713528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
